CNRS Innovation Overview
- Year Founded
-
1992
- Status
-
Private
- Employees
-
127
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
1
- Investments
-
13
CNRS Innovation General Information
Description
Provider of consultancy and support services based in France. The company guides its clients in its projects from the evaluation of technologies to the development of the operating strategy through intellectual property analysis, thereby enabling the seeking of industrial partners, negotiating and drafting of exploitation agreements and management of patent portfolios.
Contact Information
Website
www.cnrsinnovation.comCorporate Office
- 83 Boulevard Exelmans
- Metro line 9 Exelmans
- Paris
- France
Corporate Office
- 83 Boulevard Exelmans
- Metro line 9 Exelmans
- Paris
- France
CNRS Innovation Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CNRS Innovation Patents
CNRS Innovation Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12605367-B2 | Methods of treatment and/or prevention of disorders and symptoms related to bkca and/or sk channelophathies | Active | 16-Sep-2019 | ||
| US-20220313664-A1 | Methods of treatment and/or prevention of disorders and symptoms related to bkca and/or sk channelophathies | Active | 16-Sep-2019 |
CNRS Innovation Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
CNRS Innovation Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CNRS Innovation Investments (13)
CNRS Innovation’s most recent deal was a Accelerator/Incubator with AnotherWorld Bioscience. The deal was made on 18-Jun-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| AnotherWorld Bioscience | 18-Jun-2026 | Accelerator/Incubator | Specialty Chemicals | ||
| Quobly | 03-Jun-2026 | Early Stage VC | Application Specific Semiconductors | ||
| Quobly | 22-May-2025 | Early Stage VC | Application Specific Semiconductors | ||
| DAUMET | 28-Nov-2023 | Seed Round | Specialty Chemicals | ||
| Senscellar | 18-Jan-2023 | Accelerator/Incubator | Electronic Equipment and Instruments |
CNRS Innovation Exits (4)
CNRS Innovation’s most recent exit was on 03-Jun-2021 from Imescia. The exit was categorized as with 5 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Imescia | 03-Jun-2021 | Completed |
|
||
| G-LYTE | 20-Dec-2019 | Completed |
|
||
| G-LYTE | 01-Jan-2019 | Completed |
|
||
| CarboZym | Accelerator/Incubator | Completed |
CNRS Innovation FAQs
-
When was CNRS Innovation founded?
CNRS Innovation was founded in 1992.
-
Where is CNRS Innovation headquartered?
CNRS Innovation is headquartered in Paris, France.
-
What is the size of CNRS Innovation?
CNRS Innovation has 127 total employees.
-
What industry is CNRS Innovation in?
CNRS Innovation’s primary industry is Consulting Services (B2B).
-
Is CNRS Innovation a private or public company?
CNRS Innovation is a Private company.
-
What is CNRS Innovation’s current revenue?
The current revenue for CNRS Innovation is .
-
Who are CNRS Innovation’s investors?
Bpifrance and CNRS have invested in CNRS Innovation.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
